Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Royal Sense Ltd (ROYAL) Share Price & Fundamentals

Company Overview

Founded Year

2023

Listed Year

2024

Headquarter

Delhi, India

MD/CEO

Rishabh Arora

Website

https://www.royalsense.in

Company Facts

What we do

Royal Sense Limited supplies high-quality medical equipment, surgical instruments, consumables, diagnostics, and pharmaceuticals to hospitals, labs, and clinics, ensuring international standards.

Founded in

2,023

Market share

Emerging medical supplier with a growing footprint post-IPO in 2024; rapidly increasing revenue and client base.

Problem solved

Provides comprehensive medical and surgical supplies, simplifying procurement for healthcare providers and ensuring compliance with global quality standards.

Top clients or who we serve

Hospitals, laboratories, clinics, and institutions in healthcare sector; B2B focus serving medical institutions.

Key management

Rishabh Arora (Managing Director & CFO), Harmeet Singh (Whole Time Director).

Our journey and innovations

Started as sole proprietorship in 2015; incorporated as public limited in 2023; IPO raised Rs 9.86 Crores in 2024; expanding product range steadily.

Where we operate

Primarily India with plans to expand distribution networks further.

Top products or what we offer

Surgical accessories, medical consumables, diagnostic equipment, laboratory reagents, pharmaceuticals, sanitary products.

Top brands

-

Raw materials needed

Medical grade materials and pharmaceuticals sourced internationally and domestically.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly recurring through continuous supply contracts with healthcare providers.

Our industry position

New entrant with growing presence; building distribution network and customer base rapidly.

Financial highlights

Revenue Rs 61.73 Cr and Net Profit Rs 6.33 Cr for FY 2024-25; significant growth from previous years.

Geographical revenue split

Majority revenue from Indian domestic market.

Order book

-

Whats driving growth

Healthcare sector expansion, demand for quality medical supplies, IPO funding supporting working capital.

Our future plans

Strengthening distribution network, product portfolio expansion and exploring merger approvals to boost growth.

Our green promise

-

Our people and values

Small permanent employee base focused on quality and service; compliance-driven culture.

Key challenges ahead

Regulatory approvals, competition, supply chain consistency, and market expansion hurdles.

Interesting facts

Listed on SME platform of BSE in March 2024; rapidly scaled from proprietorship roots.

Risks and strategy

Mitigates risks through compliance, diversified product range, strong management, and prudent financial controls.

Market Footprint

Top Clients

Top Clients

Hospitals, laboratories, clinics, and institutions in healthcare sector; B2B focus serving medical institutions.

Top Products

Top Products

Surgical accessories, medical consumables, diagnostic equipment, laboratory reagents, pharmaceuticals, sanitary products.

Price Movement & Share Holding

Today's High/Low

7072.5

52 Week High/Low

65.95255.9
Past Returns

1 week

-2.7%

1 month

-18.18%

3 month

-30.77%

1 year

-70.64%

3 year

-41.34%

5 year

-41.34%

Share Holding

Promoters

62.24%

FII

0%

DII

0%

Retail

29.71%

Others

8.05%

Company Overview

Founded Year

2023

Listed Year

2024

Headquarter

Delhi, India

MD/CEO

Rishabh Arora (Managing Director & CFO)

Website

https://www.royalsense.in

Price Movement & Share Holding

Today's High/Low

7072.5

52 Week High/Low

65.95255.9

Past Returns

1 week

-2.7%

1 month

-18.18%

3 month

-30.77%

1 year

-70.64%

3 year

-41.34%

5 year

-41.34%

Share Holding

Promoters

62.24%

FII

0%

DII

0%

Retail

29.71%

Others

8.05%

Company Facts

What we do

Royal Sense Limited supplies high-quality medical equipment, surgical instruments, consumables, diagnostics, and pharmaceuticals to hospitals, labs, and clinics, ensuring international standards.

Founded in

2023

Market share

Emerging medical supplier with a growing footprint post-IPO in 2024; rapidly increasing revenue and client base.

Problem solved

Provides comprehensive medical and surgical supplies, simplifying procurement for healthcare providers and ensuring compliance with global quality standards.

Top clients or who we serve

Hospitals, laboratories, clinics, and institutions in healthcare sector; B2B focus serving medical institutions.

Key management

Rishabh Arora (Managing Director & CFO), Harmeet Singh (Whole Time Director).

Our journey and innovations

Started as sole proprietorship in 2015; incorporated as public limited in 2023; IPO raised Rs 9.86 Crores in 2024; expanding product range steadily.

Where we operate

Primarily India with plans to expand distribution networks further.

Top products or what we offer

Surgical accessories, medical consumables, diagnostic equipment, laboratory reagents, pharmaceuticals, sanitary products.

Raw materials needed

Medical grade materials and pharmaceuticals sourced internationally and domestically.

Recurring vs cyclical contribution

Revenue mainly recurring through continuous supply contracts with healthcare providers.

Our industry position

New entrant with growing presence; building distribution network and customer base rapidly.

Financial highlights

Revenue Rs 61.73 Cr and Net Profit Rs 6.33 Cr for FY 2024-25; significant growth from previous years.

Geographical revenue split

Majority revenue from Indian domestic market.

Whats driving growth

Healthcare sector expansion, demand for quality medical supplies, IPO funding supporting working capital.

Our future plans

Strengthening distribution network, product portfolio expansion and exploring merger approvals to boost growth.

Our people and values

Small permanent employee base focused on quality and service; compliance-driven culture.

Key challenges ahead

Regulatory approvals, competition, supply chain consistency, and market expansion hurdles.

Interesting facts

Listed on SME platform of BSE in March 2024; rapidly scaled from proprietorship roots.

Risks and strategy

Mitigates risks through compliance, diversified product range, strong management, and prudent financial controls.

Market Footprint

Top Clients

Top Clients

Hospitals, laboratories, clinics, and institutions in healthcare sector; B2B focus serving medical institutions.

Top Products

Top Products

Surgical accessories, medical consumables, diagnostic equipment, laboratory reagents, pharmaceuticals, sanitary products.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions